Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumio Yamagishi

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Kekkaku : [Tuberculosis]|November 22, 2005
[Chemoprophylaxis for tuberculosis]Fumio Yamagishi
Kekkaku : [Tuberculosis]|February 28, 2003
[Medical risk factors of tuberculosis and countermeasures]Fumio Yamagishi
Kekkaku : [Tuberculosis]|November 11, 2006
[The clinical features for tuberculosis in compromised hosts]Fumio Yamagishi
Kekkaku : [Tuberculosis]|November 19, 2003
[Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis]Fumio Yamagishi
Kekkaku : [Tuberculosis]|October 16, 2004
[Tuberculosis in the elderly]Fumio Yamagishi
Kekkaku : [Tuberculosis]|January 19, 2010
[Research and control of relapse tuberculosis cases]Fumio Yamagishi, Makoto Toyota
Kekkaku : [Tuberculosis]|November 22, 2005
[Current situation of contacts examination and chemoprophylaxis for persons exposed to multi-drug resistant tuberculosis in ordinance-designated cities in Japan]Yuka Sasaki, Fumio Yamagishi, Takenori Yagi
Kekkaku : [Tuberculosis]|March 22, 2002
[Tuberculosis in the patients undergoing haemodialysis in Japan, 1996]Yuka Sasaki, Fumio Yamagishi, Toru Mori
In Vivo (Athens, Greece)|July 15, 2011
Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patientsTakayo Sotsuka, Yuka Sasaki, Shigekazu Hirai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 12, 2018
Microorganisms isolated at admission and treatment outcome in sputum smear-positive pulmonary tuberculosisSatoru Ishikawa, Hidetoshi Igari, Kazutaka Yamagishi, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Kekkaku : [Tuberculosis]|November 22, 2005
[Chemoprophylaxis for tuberculosis]Fumio Yamagishi
Kekkaku : [Tuberculosis]|February 28, 2003
[Medical risk factors of tuberculosis and countermeasures]Fumio Yamagishi
Kekkaku : [Tuberculosis]|November 11, 2006
[The clinical features for tuberculosis in compromised hosts]Fumio Yamagishi
Kekkaku : [Tuberculosis]|November 19, 2003
[Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis]Fumio Yamagishi
Kekkaku : [Tuberculosis]|October 16, 2004
[Tuberculosis in the elderly]Fumio Yamagishi
Kekkaku : [Tuberculosis]|January 19, 2010
[Research and control of relapse tuberculosis cases]Fumio Yamagishi, Makoto Toyota
Kekkaku : [Tuberculosis]|November 22, 2005
[Current situation of contacts examination and chemoprophylaxis for persons exposed to multi-drug resistant tuberculosis in ordinance-designated cities in Japan]Yuka Sasaki, Fumio Yamagishi, Takenori Yagi
Kekkaku : [Tuberculosis]|March 22, 2002
[Tuberculosis in the patients undergoing haemodialysis in Japan, 1996]Yuka Sasaki, Fumio Yamagishi, Toru Mori
In Vivo (Athens, Greece)|July 15, 2011
Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patientsTakayo Sotsuka, Yuka Sasaki, Shigekazu Hirai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 12, 2018
Microorganisms isolated at admission and treatment outcome in sputum smear-positive pulmonary tuberculosisSatoru Ishikawa, Hidetoshi Igari, Kazutaka Yamagishi, et al.
Pageof 4